Company
Headquarters: Taipei, Taiwan
TW$13.93 Billion
TWD as of July 1, 2024
US$427.9 Million
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
YungShin Global Holding Corporation, through its subsidiaries, produces and sells pharmaceutical products. The company offers medicines and feed additives for swine, ruminants, poultry, pets, and aquatics; APIs, API intermediates, and specialty chemicals, as well as CRO and CMO services; herbal products; health foods; and beauty care products. It also operates EYES testing laboratories for food safety testing; and offers western medicines, agricultural products, chemical intermediates, and over-the-counter medicines. In addition, the company imports and exports pharmaceuticals, APIs, bio-products, and functional food materials; exports medicine-manufacturing machines and components, and medicine/food ingredients, as well as related materials, such as ampoules and vials; imports tablet-analysis equipment; and operates a nursing home for senior care. It operates in Taiwan, China, the United States, Japan, Malaysia, Hong Kong, Singapore, Thailand, Indonesia, Cambodia, and South Africa. The company was founded in 1952 and is based in Taipei, Taiwan.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
YungShin Global Holding Corp has the following listings and related stock indices.
Stock: TWSE: 3705 wb_incandescent